Protein Restriction (PR) for Weight Loss
PR
1 other identifier
interventional
15
1 country
1
Brief Summary
Prolonged dietary protein restriction has been shown to increase energy expenditure in mice simultaneously with an increase in plasma FGF21 levels. In overfeeding studies, a protein-restricted diet reduces weight gain in both mice and humans compared with normal and high-protein diets. Further, in energy balance studies, when lean men are provided with a protein-restricted diet for five weeks, an increase in energy intake was necessary to obtain their body weight. However, whether the effect of a protein-restricted diet is the same when consumed by overweight to obese men has divergent results in both mice and humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
February 8, 2024
CompletedFirst Posted
Study publicly available on registry
February 16, 2024
CompletedFebruary 16, 2024
February 1, 2024
2.2 years
February 8, 2024
February 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Body weight
The effect of a prolonged moderate protein-restricted diet on body weight in obese participants.
5 weeks
Secondary Outcomes (1)
FGF21
5 weeks
Study Arms (2)
Restricted dietary protein
EXPERIMENTAL5 week intake of a isocaloric diet restricted in protein
Habitul diet
EXPERIMENTAL5 week intake of habitual, high protein diet
Interventions
Participants will be allocated to 5 week isocaloric restricted protein intake
Participants will be follow their habitual, high protein intake
Eligibility Criteria
You may qualify if:
- BMI between 26 and 32 Low physical activity level Non-smoker Not using snuff Not suffering from diabetes, hypertension, or any daily medication use High protein intake (≥1,5 g/kg body weight/day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Copenhagen
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bente Kiens, D.Sci
University of Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2024
First Posted
February 16, 2024
Study Start
October 1, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
February 16, 2024
Record last verified: 2024-02